Efficiency of Biomarker-Driven Clinical Trial Designs

被引：2
|
作者：
Freidlin, Boris [1 ]
Korn, Edward L. [1 ]
机构：
[1] NCI, Biometr Res Program, Div Canc Treatment & Diag, Biostat Branch, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 12期
关键词：
D O I：
10.1200/JCO.23.02581
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Stratified Medicine: Maximizing Clinical Benefit by Biomarker-Driven Health Care
    Singh, Sharat
    NEXT-GENERATION NUTRITIONAL BIOMARKERS TO GUIDE BETTER HEALTH CARE, 2016, 84 : 91 - 102
  • [22] Biomarker driven clinical trial
    Lin, Yung-Chang
    CANCER SCIENCE, 2018, 109 : 423 - 423
  • [23] A risk management approach for imaging biomarker-driven clinical trials in oncology
    Liu, Yan
    deSouza, Nandita M.
    Shankar, Lalitha K.
    Kauczor, Hans-Ulrich
    Trattnig, Siegfried
    Collette, Sandra
    Chiti, Arturo
    LANCET ONCOLOGY, 2015, 16 (16): : E622 - E628
  • [24] Biomarker-Driven Oncology Trial Design and Subgroup Characterization: Challenges and Potential Solutions
    Wang, Jian
    Yu, Binbing
    Dou, Yannan Nancy
    Mascaro, Jacques
    JCO PRECISION ONCOLOGY, 2024, 8
  • [25] What’s new with biomarker-driven clinical strategy in sepsis and circulatory failure?
    Armand Mekontso Dessap
    Lorraine B. Ware
    Lila Bouadma
    Intensive Care Medicine, 2016, 42 : 418 - 421
  • [26] Biomarker-adaptive clinical trial designs
    Freidlin, Boris
    Korn, Edward L.
    PHARMACOGENOMICS, 2010, 11 (12) : 1679 - 1682
  • [27] STUDY DESIGNS FOR CLINICAL TRIAL USING BIOMARKER
    Yamamoto, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 72 - 72
  • [28] Biomarker-driven targeting of NAD metabolism in rhabdomyosarcoma
    Vasquez, Juan C.
    Bhardwaj, Prateek
    Zhao, Sophia
    Noronha, Katelyn
    Lucas, Karlie
    Sundaram, Ranjini
    Heer, Collin
    Morotti, Raffaella
    Spurrier, Josh
    Bindra, Ranjit S.
    CANCER RESEARCH, 2024, 84 (17)
  • [29] Biomarker-Driven Early Clinical Trials in Oncology A Paradigm Shift in Drug Development
    Tan, Daniel S. W.
    Thomas, George V.
    Garrett, Michelle D.
    Banerji, Udai
    de Bono, Johann S.
    Kaye, Stan B.
    Workman, Paul
    CANCER JOURNAL, 2009, 15 (05): : 406 - 420
  • [30] What's new with biomarker-driven clinical strategy in sepsis and circulatory failure?
    Dessap, Armand Mekontso
    Ware, Lorraine B.
    Bouadma, Lila
    INTENSIVE CARE MEDICINE, 2016, 42 (03) : 418 - 421
12345